Virchow Medical, manufacturer of the Crow’s Nest® Biopsy Catchment System and operator of the Virchow VaultTM Liquid Specimen Biorepository, announced it has completed a...
Vaxess Technologies announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.
Boston-based Terrestrial Bio rebranded to reflect its strategic...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Real-world evidence demonstrated the long-term performance and positive...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
Virchow Medical, manufacturer of the Crow’s Nest® Biopsy Catchment System and operator of the Virchow VaultTM Liquid Specimen Biorepository, announced it has completed a...
Vaxess Technologies announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.
Boston-based Terrestrial Bio rebranded to reflect its strategic...